Ionis Pharmaceuticals (IONS) Debt to Equity (2016 - 2025)
Historic Debt to Equity for Ionis Pharmaceuticals (IONS) over the last 17 years, with Q3 2025 value amounting to $1.02.
- Ionis Pharmaceuticals' Debt to Equity rose 142100.24% to $1.02 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.02, marking a year-over-year increase of 142100.24%. This contributed to the annual value of $0.09 for FY2024, which is 6039.55% down from last year.
- Latest data reveals that Ionis Pharmaceuticals reported Debt to Equity of $1.02 as of Q3 2025, which was up 142100.24% from $1.0 recorded in Q2 2025.
- In the past 5 years, Ionis Pharmaceuticals' Debt to Equity registered a high of $1.02 during Q3 2025, and its lowest value of $0.02 during Q1 2023.
- For the 5-year period, Ionis Pharmaceuticals' Debt to Equity averaged around $0.24, with its median value being $0.13 (2024).
- As far as peak fluctuations go, Ionis Pharmaceuticals' Debt to Equity tumbled by 8348.47% in 2021, and later soared by 142100.24% in 2025.
- Over the past 5 years, Ionis Pharmaceuticals' Debt to Equity (Quarter) stood at $0.08 in 2021, then tumbled by 65.97% to $0.03 in 2022, then skyrocketed by 699.23% to $0.22 in 2023, then tumbled by 60.4% to $0.09 in 2024, then surged by 1056.83% to $1.02 in 2025.
- Its Debt to Equity was $1.02 in Q3 2025, compared to $1.0 in Q2 2025 and $0.09 in Q4 2024.